Search

everythinglearnresearchcommunity

for

Search:↓

SCAD can indicate ANA-negative lupus, especially in women with unusual symptoms.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

If someone has scaly skin, muscle stiffness, and intellectual disability, doctors should consider Sjogren-Larsson Syndrome, but other conditions if more symptoms are present.

Different sPLA2 enzymes have unique roles in phospholipid metabolism and biological processes.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Targeting LPA could help treat skin disorders.

SMAs improve patient satisfaction and may be cost-effective for female hair loss.

Chronic scarring alopecia is common in SLE patients and needs early detection and management.

Early detection of Graham-Little-Piccardi-Lasseur syndrome is key for better management.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

CARASIL, a rare genetic disorder, was confirmed in an Arabic woman, highlighting its rarity and need for stroke prevention.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Mice with too much sPLA₂-IIA have hair loss and poor wound healing due to abnormal hair growth and stem cell depletion.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Early intervention is important for limited systemic sclerosis patients due to higher pain and ulceration risks.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

A new genetic mutation in the CAST gene may link PLACK syndrome to alopecia areata.

Phospholipase A2 enzymes play key roles in skin health and disease.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

SLFC can improve scalp health and reduce sensitive scalp symptoms.

The document concludes that treatment improved skin lesions but not scalp hair loss in two patients with Graham-Little-Piccardi-Lassueur syndrome.

Overexpression of sPLA2-IIA in mouse skin reduces hair stem cells and increases cell differentiation through JNK/c-Jun pathway activation.

Graham-Little Piccardi Lassueur Syndrome is a rare skin condition with specific hair loss and skin symptoms.

Polysulfonic acid mucopolysaccharide can reduce skin scarring.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The patient has Chronic Cutaneous Lupus, a skin condition causing plaques and hair loss.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Hyaluronic acid filler injections are a favored non-surgical method to improve facial aging signs due to their convenience, effectiveness, and durability.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.